Bariatrics clinical trial - Celgene RPC01-3202

Bariatrics

Status:

Active and Enrolling

ClinicalTrials.gov:

NCT03440385

Celgene RPCO1-3202

Drug

Ozanimod/ Placebo

Phase

III

Condition

Chron's Disease